CTLT - Catalent Inc.
Close
60.96
0.010 0.016%
Share volume: 2,001,078
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$60.95
0.01
0.02%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-08-29 | 2022-11-01 | 2023-02-07 | 2023-06-12 | 2023-12-08 | 2023-12-08 | 2024-02-14 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 10.507 B | 10.205 B | 11.147 B | 10.830 B | 10.777 B | 10.023 B | 9.988 B | 9.879 B | |
| Current Assets | 2.916 B | 2.698 B | 2.918 B | 2.738 B | 2.692 B | 2.614 B | 2.570 B | 2.523 B | |
| Inventories | 702.000 M | 732.000 M | 818.000 M | 744.000 M | 777.000 M | 796.000 M | 775.000 M | 742.000 M | |
| Other Current Assets | 625.000 M | 632.000 M | 714.000 M | 693.000 M | 633.000 M | 779.000 M | 723.000 M | 744.000 M | |
| Short Term Investments | 625.000 M | 632.000 M | 714.000 M | 693.000 M | 633.000 M | 779.000 M | 723.000 M | 744.000 M | |
| Total Receivables | 1.051 B | 989.000 M | 916.000 M | 1.049 B | 1.002 B | 830.000 M | 843.000 M | 875.000 M | |
| Current Cash | 538.000 M | 345.000 M | 470.000 M | 252.000 M | 280.000 M | 209.000 M | 229.000 M | 162.000 M | |
| Total Non-current Assets | 7.591 B | 7.507 B | 8.229 B | 8.092 B | 8.085 B | 7.409 B | 7.418 B | 7.356 B | |
| Property Plant Equipment | 3.127 B | 3.167 B | 3.579 B | 3.671 B | 3.682 B | 3.723 B | 3.777 B | 3.735 B | |
| Other Assets | 188.000 M | 349.000 M | 335.000 M | 344.000 M | 193.000 M | 328.000 M | 324.000 M | 341.000 M | |
| Intangible Assets | 1.060 B | 1.017 B | 1.045 B | 1.012 B | 980.000 M | 942.000 M | 911.000 M | 875.000 M | |
| Goodwill | 3.006 B | 2.929 B | 3.215 B | 3.023 B | 3.039 B | 2.316 B | 2.351 B | 2.339 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.507 B | 10.205 B | 11.147 B | 10.830 B | 10.777 B | 10.023 B | 9.988 B | 9.879 B | |
| Total liabilities | 5.712 B | 5.505 B | 6.235 B | 6.127 B | 6.166 B | 6.182 B | 6.301 B | 6.268 B | |
| Total current liabilities | 1.072 B | 943.000 M | 1.526 B | 1.487 B | 1.530 B | 1.534 B | 1.036 B | 1.007 B | |
| Accounts Payable | 421.000 M | 379.000 M | 367.000 M | 394.000 M | 424.000 M | 367.000 M | 407.000 M | 377.000 M | |
| Other liabilities | 267.000 M | 250.000 M | 267.000 M | 260.000 M | 247.000 M | 258.000 M | 256.000 M | 264.000 M | |
| Current long term debt | 31.000 M | 106.000 M | 632.000 M | 588.000 M | 536.000 M | 624.000 M | 46.000 M | 47.000 M | |
| Long term debt | 4.171 B | 4.098 B | 4.221 B | 4.261 B | 4.313 B | 4.322 B | 4.959 B | 4.933 B | |
| Other liabilities | 267.000 M | 250.000 M | 267.000 M | 260.000 M | 247.000 M | 258.000 M | 256.000 M | 264.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.795 B | 4.700 B | 4.912 B | 4.703 B | 4.611 B | 3.841 B | 3.687 B | 3.611 B | |
| Common stock | 178.000 M | 180.000 M | 181.000 M | 181.000 M | 182.000 M | 181.000 M | 182.000 M | 182.000 M | |
| Retained earnings | 538.000 M | 538.000 M | 619.000 M | 372.000 M | 262.000 M | -497.000 M | -703.000 M | -804.000 M |